Cited by 233RNA modifications and cancerRNA regulation and diseaseCancer-related gene regulation

RNA m6A modification and its function in diseases

Open access
Tong, Jiyu, Flavell, Richard A., Li, Hua-Bing·2018·Frontiers of Medicine

Abstract

N 6 -methyladenosine (m 6 A) is the most common post-transcriptional RNA modification throughout the transcriptome, affecting fundamental aspects of RNA metabolism. m 6 A modification could be installed by m 6 A “writers” composed of core catalytic components (METTL3/METTL14/WTAP) and newly defined regulators and removed by m 6 A “erasers” (FTO and ALKBH5). The function of m 6 A is executed by m 6 A “readers” that bind to m 6 A directly (YTH domain-containing proteins, eIF3 and IGF2BPs) or indirectly (HNRNPA2B1). In the past few years, advances in m 6 A modulators (“writers,” “erasers,” and “readers”) have remarkably renewed our understanding of the function and regulation of m 6 A in different cells under normal or disease conditions. However, the mechanism and the regulatory network of m 6 A are still largely unknown. Moreover, investigations of the m 6 A physiological roles in human diseases are limited. In this review, we summarize the recent advances in m 6 A research and highlight the functional relevance and importance of m 6 A modification in in vitro cell lines, in physiological contexts, and in cancers.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11684-018-0654-8

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Gokhale NS, McIntyre ABR, McFadden MJ, Roder AE, Kennedy EM, Gandara JA, Hopcraft SE, Quicke KM, Vazquez C, Willer J, Ilkayeva OR, Law BA, Holley CL, Garcia-Blanco MA, Evans MJ, Suthar MS, Bradrick SS, Mason CE, Horner SM. N 6 -methylade- nosine in flaviviridae viral RNA genomes regulates infection. Cell Host Microbe 2016; 20(5): 654-665
  2. Chen M, Wei L, Law CT, Tsang FH, Shen J, Cheng CL, Tsang LH, Ho DW, Chiu DK, Lee CC JM, Wong IO, Ng CM, Wong. RNA N 6 - methyladenosine methyltransferase METTL3 promotes liver cancer progression through YTHDF2 dependent post-transcriptional silen- cing of SOCS2. Hepatology 2018; 67(6):2254-2270

Cited by

Sorted by citations

Authors
Tong, J., Flavell, R. A., & Li, H.-B.
Affiliations
  • Shanghai Jiao Tong University (CN)
  • Howard Hughes Medical Institute (US)
Corresponding author
Flavell, Richard A.
Venue
Frontiers of Medicine
Published
2018-08
Volume
12
Issue
4
Pages
481-489
ISSN
  • 1673-7342 (ISSN-L)
  • 2095-0217
  • 2095-0225
OpenAlex
W2885250628
Cited by
233
References
72
Citations by year
2026: 7 · 2025: 16 · 2024: 28 · 2023: 41 · 2022: 42 · 2021: 37 · 2020: 45 · 2019: 16 · 2018: 1
FWCI
2.48
Type
journal article
Language
en
Open access
Locations
  • Frontiers of Medicine (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Howard Hughes Medical Institute
  • National Natural Science Foundation of China (91753141)
  • Shanghai Jiao Tong University
  • School of Medicine, Shanghai Jiao Tong University
  • Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
Keywords
N6-methyladenosine, m6A RNA methylation, post-transcriptional RNA modification, m6A writers, m6A erasers, m6A reader, FTO, ALKBH5, YTH domain proteins, IGF2BP, HNRNPA2B1, eIF3, cancer, human disease, RNA metabolism
MeSH terms
Adenosine, Cell Differentiation, Humans, Neoplasms, RNA, RNA Processing, Post-Transcriptional

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review